Adiv Johnson, PhD

Adiv Johnson, PhD, has dedicated nearly 20 years to the field of aging research, contributing more than 50 peer-reviewed publications relevant to aging, age-related disease, and regenerative medicine. After earning his PhD in Physiological Sciences from the University of Arizona, he completed a postdoctoral fellowship in the Department of Ophthalmology at the Mayo Clinic. Adiv's expertise in aging biomarkers, paired with a longstanding passion for improving longevity, led him to join the founding team of the company Tally Health, which was ultimately acquired by Infinite Epigenetics. Adiv currently serves as the VP of Scientific Affairs for TruDiagnostic.